Status:
COMPLETED
Evaluation of the Alcohol Elimination Effect of TCI711 Probiotic (Bacillus Coagulans) on Adult Individuals
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Breath Alcohol Level
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Investigating the possibility of using Bacillus coagulans TCI711 to improve the efficiency of alcohol removal in adult individuals.
Eligibility Criteria
Inclusion
- Healthy volunteers aged between 20 to 60.
- Systolic pressure below 140
- Score of C-CAGE Questionnaire below 8 (male)/6 (female)
- Prohibiting other supplements before 2 weeks of the study and during the study
- Prohibiting alcohol drinks before 24 hours of the study
- Prohibiting caffeine drinks before 12 hours of the study
Exclusion
- Alcohol or drug allergy
- Liver, kidney, cardiovascular, or chronic diseases
- Other severe disorders
- Hypertension
- Pregnancy or lactation
- Already involved in clinical testing
- Other supplements
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04457661
Start Date
July 13 2020
End Date
December 31 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GeNext
Taipei, Taiwan, 114